We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.
- support healthcare innovation and technology that will benefit patients now and in the future
- drive faster translation of basic science discoveries into tangible benefits for patients and the economy
- help develop the people who conduct and contribute to applied health research.
About the ABPI
We represent innovative biopharmaceutical companies in the UK.
Our industry, a major contributor to the economy, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing new medicines, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI also negotiates for the branded pharmaceutical industry in statutory consultations, including the pricing scheme for medicines in the UK.
The NIHR is funded by the UK government to improve the health and wealth of the nation through research and represents the most integrated health research system in the world. We partner with all funders of research, including industry, to:
More about us: https://www.nihr.ac.uk/partners-and-industry/industry/
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 26,000 people worldwide, we provide comprehensive drug development solutions and are on a mission to advance health and power clear, confident decisions.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise.
Together with our clients, Covance by Labcorp supports the development of innovative, life-changing treatments. Visit us at www.covance.com.
PPD is delighted to sponsor PharmaTimes International Clinical Researcher of the Year 2021.
PPD is a leading global contract research organisation providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organisations. With locations in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.
As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.
Whether it's developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.
Karen Brown, Vice President